Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Beloranib

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome

Zafgen · Phase 2 · Completed · Enrollment 17

NCT01818921

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.